Careers  |  Sign In  |  Register  |   Twitter

Disappointing Setback for Inhaled Diabetes Drug

The first inhaled insulin product, Exubera, has been discontinued due to dosing issues and pulmonary lung function test concerns.

References and Resources

Drug to be Discontinued; Exubera (insulin recombinant human, powder for inhalation).

Click Here to view the discontinuation list from the FDA.

Sponsored by The Doctor’s Channel